0
Is olaparib the only PARP inhibitor that has been approved?
- 1 people answered
0 Vote
1 Contributor
1446 Views 
0 Saved
0 Vote 1 Contributor1446 Views 0 SavedYou might also be interested in
Dear sir, I have suffering from Peptic ulcer from 7 years back and still now, if there any treatment from ur hand so please kindly suggest me.
You may find the hot flashes gradually decreasing with time after you start taking Arimidex; many women do. But we're talking years, not months, for them to vanish entirely. Some women even deal with hot flashes (usually much less intense and much less frequent) for the rest of their lives. Don't m....
Charges of biopsy
Rahul Sharma
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy. For the treatment of adult patients with suspected deleterious germline BRCA-mutated advanced ovarian cancer which has been treated with 3 or more prior lines of chemotherapy. Patients should be selected for therapy based on an FDA-approved companion diagnostic for LYNPARZA. Poly (ADP-ribose) Polymerase, or PARP, enzymes mediate DNA repair by transferring ADP-ribose units to preexisting ADP-ribose chains on proteins and to proteins. This ADP–ribosylation process recruits DNA repair enzymes, thereby maintaining genomic integrity. Inhibiting this process can lead to the accumulation of DNA damage and, ultimately, cell death.